February 2018

With Approval of CAR T-Cell Therapy Comes the Next Challenge: Payer Coverage

February 22, 2018

Evidence-Based Oncology

CAR T- cell therapies are among the most expensive ever invented. For now, there’s a lot of uncertainty, as both government and commercial insurers, and a handful of the nation’s leading cancer centers, navigate a reimbursement structure that truly has no precedent.

The Clinical Trial and the Patient's Voice: "I'm Extremely Lucky to Be Alive"

February 21, 2018

Evidence-Based Oncology

Two stories--of taking part in clinical trials, and of serving as a voice for patients among scientists who run them--highlight how the advances in cancer are built on the trust between those living with the disease and the clinicians on the frontiers of care.